GCC Real Estate Family Office Competitive Insight Case Study

GCC Real Estate Family Office Competitive Insight Case Study

Background

Our client was a prominent GCC family with diversified business interests throughout real estate, manufacturing, and industry. The family had established an early footprint in healthcare, driven by their desire to build a foundation in the sector. With strong backing, their target was to become one of the largest dialysis groups in the country. The natural next step was to secure a hemodialysis machine agency. So they could be utilised for home hemodialysis and ambulatory settings.

Because some of the top dialysis machine agents in the country are closely connected to dialysis service providers, this strategy made sense. It would provide capabilities and prestige, employing its excellent and growing market reputation to secure face time with key officials at health authorities, although it lacks a strong initial healthcare foundation. Furthermore, owning their own devices would protect them from competitor reactions, reduce costs, and increase profitability, particularly through accessories.

We were brought in because the family noticed a lack of early demand and local inquiries for the European brand they had chosen. While they expected these inquiries to occur naturally, that expectation may not hold for this product category.

What Was Happening

With the rise of chronic illnesses like diabetes and high blood pressure, the rate of chronic kidney disease (CKD) was climbing. Consequently, the government was encouraging the private sector to step in. This involved taking over the management of existing dialysis centres and constructing new facilities to meet the required capacity over the coming decades. Under this model, insurance companies would cover the treatment costs of insured patients, while the private sector would invest in building world-class centres and clinics, often partnering with international dialysis service providers, consultants and manufacturers.

Key Questions

We understand that hemodialysis machines serve chronically ill patients who are already in a fragile state, many of whom have multiple co-morbidities. Therefore, purchasing decisions are not made solely by procurement executives. At this early stage, our goal is to validate the business idea and market requirements by answering the following questions:

1. How well-known are these hemodialysis machines and consumables in the market?
2. What are the views of key hospital personnel (procurement officers, biomedical engineers, and dialysis technicians) at dialysis centres and home hemodialysis units?
3. Who are the ultimate decision makers regarding the types of dialysis machines and consumables used?
4. How do key personnel at dialysis centres and facilities feel about switching to an alternative brand of hemodialysis machines or consumables?
5. What did key opinion leaders (KOLs) in dialysis centres and facilities, who are usually heads of departments and consultant nephrologists, know about these devices?
6. Given that the manufacturer commonly participates in international scientific and commercial events relevant to healthcare, nephrology, and dialysis, had they previously failed to enter this market?
7. What is the international company’s history of successful commercial implementation globally and across the MENA region, especially in countries where most local nephrologists were trained or from which they originated? Widespread successful implementation in those home countries might significantly aid negotiations.

What We Did

We worked alongside dialysis operations specialists to explore this case and conduct on-the-ground research. And we visited centres, doctors, and KOLs. Speaking openly about the devices while identifying ourselves as affiliates of the local agent, as agreed with the family. We also spoke alongside health authorities and officials responsible for dialysis in government hospitals, public health sectors, and humanitarian organisations.

Simultaneously, we reviewed supporting resources and conducted calls with stakeholders in neighbouring GCC countries and the home countries of local KOLs to investigate the manufacturer’s footprint. This formed the early validation stage. While we usually conduct comprehensive market and competitive analyses for such projects, our expertise and early consultations with dialysis specialists indicated that attention should remain on validation.

The Results

While the manufacturer’s products were quite affordable. They had achieved some success in low- and lower-middle-income countries, but local stakeholders were hesitant. Due to strict regulations and an obligation to build a world-class healthcare system, the local market consistently favours the best. The most established and latest technologies.

Our Recommendations

Our strategic recommendation was to shelve this project and stop allocating resources to pursuing representation for this European brand. Clinically, risk-averse nephrologists will not readily switch fragile, chronic patients to an unproven brand. And health authorities will not be comfortable relying on an untested and unknown product in the country when lives are at stake. Commercially, establishing an unfamiliar product requires a long, capital-intensive validation cycle.

This decision allowed our client to redirect their resources more productively. So, avoiding a costly and unsuccessful setup, inventory expenses, and the cost of a dedicated team.

Following our recommendations, they shifted their approach. They contacted the top three local providers of dialysis machines to present their long-term plans. Then requested meetings with senior management at the local agencies rather than standard Biomedical sales specialists. This allowed them to build long-term partnerships. One of the main global players in dialysis machines and consumables was keen on collaborating. As intense market competition and rival players with strong institutional backing were challenging their market position.

About Octopus Intelligence, the UK and Dubai-based Competitive Insights Consultancy

Octopus is a global competitive insights consultancy with offices in the UK and Dubai.

Our Dubai team works with businesses competing across the Gulf and those looking to enter the region successfully. We combine deep human intelligence with rigorous secondary research to give MENA clients a clear picture of their competitive landscape. Who is moving, how, and why.

We work with MENA and UAE-based businesses across technology, healthcare, financial services, manufacturing, and private equity. Our work covers competitor profiling, market mapping, strategic early warning, and deal-level intelligence for investors and acquirers.

Outsmart your competition. Make the unknown known. Octopus helps you gain clarity in complex markets. With clients and tentacles around the MENA, we deliver sharp, actionable competitive insights through a blend of deep primary (talking to people) and secondary research. If you’re looking to make smarter decisions, beat the competition, and reduce uncertainty, we’re the partner you want on your side.

If you compete in the Gulf and want sharper answers, contact our Dubai team below:

mohamed@octopusintelligence.com | Executive Director – MENA | +971 56 535 3198 | Dubai Digital Park, Dubai Silicon Oasis, Dubai, United Arab Emirates